The Use of Xpert MTBRif for Active Case Finding among TB Contacts in North West Province, South Africa

Abstract EN

Introduction.

Tuberculosis is a major cause of morbidity and mortality especially in high HIV burden settings.

Active case finding is one strategy to potentially reduce TB disease burden.

Xpert MTB/Rif has recently been recommended for diagnosis of TB.

Methods.

Pragmatic randomized trial to compare diagnosis rate and turnaround time for laboratory testing for Xpert MTB/Rif with TB microscopy and culture in household contacts of patients recently diagnosed with TB.

Results.

2464 household contacts enrolled into the study from 768 active TB index cases.

1068 (44%) were unable to give sputum, but 24 of these were already on TB treatment.

863 (53%) participants sputum samples were tested with smear and culture and 2.7% (23/863; CI: 1.62–3.78) were diagnosed with active TB.

Xpert MTB/Rif was used in 515 (21%) participants; active TB was diagnosed in 1.6% (8/515; CI: 0.52–2.68).

Discussion and Conclusions.

Additional 31 cases were diagnosed with contact tracing of household members.

When Xpert MTB/Rif is compared with culture, there is no significant difference in diagnostic yield.